糖尿病患者牵拉性视网膜脱离行平坦部玻璃体切除术的结局与并发症:系统综述与Meta分析
该系统综述与Meta分析纳入38项研究共3839只眼,评估平坦部玻璃体切除术(PPV)治疗糖尿病性牵拉性视网膜脱离(dTRD)的解剖与功能结局。一次手术后视网膜复位失败率为5.9%(95%CI 1.4%-8.3%),平均最终视力为0.94 logMAR(95%CI 0.82-1.05)。术前视力较高是唯一与术后视力较高相关的因素,作者认为PPV是有效策略,可考虑早期干预并与患者详细讨论。
要点
- 一次PPV术后视网膜复位失败率为5.9%(95%CI 1.4%-8.3%),平均最终视力0.94 logMAR。
- 术前视力每差1.0 logMAR,最终视力差0.66 logMAR(95%CI 0.39-0.84;P<.001)。
- 多变量分析中其他患者特征或手术变量与结局无统计学显著关联。
核心结论
- 该系统综述与Meta分析结果提示,PPV是使dTRD患者实现视网膜复位的有效策略。
- 鉴于术前视力较高是唯一与术后视力较高相关的因素,作者认为可考虑早期干预并与患者详细讨论。
- 总体术后最终视力仍较低,应就dTRD预后不良对患者进行咨询。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE和Embase自2000年1月1日至2022年2月20日,并筛选合格研究的参考文献列表。
- 纳入标准为英文发表、报告PPV治疗dTRD的结局、纳入超过25只眼且随访至少3个月的研究。
- 共识别406项研究,最终纳入38项研究(3839只眼)进行分析。
- 遵循PRISMA指南进行数据提取与合成,使用美国国家卫生研究院质量评估工具评估偏倚风险。
- 研究资格由2名评价者独立确定;数据由1名评价者提取并由另一名评价者核对准确性;采用随机效应模型合并数据。
主要发现
- 患者中位(IQR)年龄为52.2(49.6-55.7)岁;在报告患者性别的31项研究中,女性1441例(50.1%)。
- 一次手术后视网膜复位总体失败率为5.9%(95%CI 1.4%-8.3%),平均最终视力为0.94 logMAR(95%CI 0.82-1.05)(约Snellen等效6/53;95%CI 6/39-6/71)。
- 术前视力较高者术后视力较高:基线视力每差1.0 logMAR,最终视力差0.66 logMAR(95%CI 0.39-0.84;P<.001)。
- 多变量分析中,其他患者特征或手术变量与结局均无统计学显著关联。
临床怎么用
- 作者认为,鉴于术前视力较高是唯一与术后视力较高相关的因素,可考虑早期干预并与患者详细讨论。
- 作者指出,总体术后最终视力仍较低,应就dTRD预后不良对患者进行咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Tractional retinal detachment (TRD) occurs in approximately 5% of people with proliferative diabetic retinopathy and poses a threat to vision. Pars plana vitrectomy (PPV) is the treatment of choice for TRD. OBJECTIVE: To determine anatomic and functional outcomes of PPV for the treatment of TRD in people with diabetes (dTRD). DATA SOURCES: MEDLINE and Embase were searched systematically from January 1, 2000, to February 20, 2022. In addition, a reference list of eligible studies were screened. STUDY SELECTION: Eligible studies were those published in English, those reporting outcomes of PPV for dTRD, and those that included more than 25 eyes and with a minimum follow-up of 3 months. DATA EXTRACTION AND SYNTHESIS: Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines for data extraction/synthesis were followed, and the National Institute for Health quality assessment tool was used to assess risk of bias. Study eligibility was determined independently by 2 reviewers; data extraction was conducted by 1 reviewer and entries checked for accuracy by another. Data were pooled using a random-effects model. MAIN OUTCOMES AND MEASURES: Main outcomes included rate of failure of retinal reattachment following 1 surgery and final visual acuity (VA). The association of baseline patient characteristics and surgical maneuvers with postoperative surgical outcomes was investigated. RESULTS: Of the 406 studies identified, 38 (3839 eyes) were eligible and included for analysis. Patients had a median (IQR) age of 52.2 (49.6-55.7) years. In the studies reporting patient sex (31 of 38 studies), 1441 were female individuals (50.1%). The overall failure rate of retinal reattachment after 1 surgery was 5.9% (95% CI, 1.4%-8.3%), and the mean final VA was 0.94 (95% CI, 0.82-1.05) logMAR (approximate Snellen equivalent, 6/53; 95% CI, 6/39-6/71). People with higher preoperative VA achieved higher postoperative vision (0.66 logMAR worse final vision; 95% CI, 0.39-0.84 per 1.0 logMAR worse at baseline; P <.001). On multivariable analysis, no other patient characteristics or surgical variables had a statistically significant association with outcomes. CONCLUSIONS AND RELEVANCE: Results of this systematic review and meta-analysis suggest that PPV was an effective strategy to achieve retinal reattachment in people with dTRD. Given that higher preoperative VA was the only factor associated with higher postoperative vision, early intervention should be considered and discussed in detail with patients. Overall, final postoperative VA remains low, and patients should be counseled on the guarded prognosis of dTRD.
引用
- McCullough P, Mohite A, Virgili G, et al. Outcomes and Complications of Pars Plana Vitrectomy for Tractional Retinal Detachment in People With Diabetes: A Systematic Review and Meta-analysis. JAMA Ophthalmol. 2023. PMID: 36633878. doi:10.1001/jamaophthalmol.2022.5817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。